Hammond, Olivia <br/><br/>
Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial.  [electronic resource] 

 -  Journal of immunoassay & immunochemistry  2008 
 - 332-47 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-4230 
<br/><br/><label>Standard No.: </label>10.1080/15321810802329518  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Vaccines--immunology<br/>Amyloid beta-Peptides--immunology<br/>Animals<br/>Clinical Trials as Topic<br/>Enzyme-Linked Immunosorbent Assay--standards<br/>Humans<br/>Immunoglobulin G--blood<br/>Peptide Fragments--immunology<br/>Research Design--standards